---
figid: PMC5869671__41598_2018_23324_Fig1_HTML
figtitle: NF-kB2 Genetic Variations are Significantly Associated with Non-Small Cell
  Lung Cancer Risk and Overall Survival
organisms:
- NA
pmcid: PMC5869671
filename: 41598_2018_23324_Fig1_HTML.jpg
figlink: /pmc/articles/PMC5869671/figure/Fig1/
number: F1
caption: '(A) Schematic diagram of the alternative pathway of NF-kB (Reprinted from
  Lung Cancer, 89, 3, Dimitrakopoulos et al., 311–319, Variant of BCL3 gene is strongly
  associated with five-year survival of non-small-cell lung cancer patients, 2015,
  with permission from Elsevier). (B) Genomic positions of studied SNPs in NF-kB2
  gene. (C) The study design outline. Abbreviations: BAFFR; tumor necrosis factor
  receptor superfamily member 13 C, CD40; CD40 molecule, TNF receptor superfamily
  member 5, LTβR; Lymphotoxin Beta Receptor (TNFR Superfamily, Member 3), RANK; Receptor
  Activator Of Nuclear Factor-Kappa B, NIK; NF-Kappa-Beta-Inducing Kinase, IKKα; IκB
  Kinase α, p100; nuclear factor NF-kappa-B p100 subunit, p52; nuclear factor NF-kappa-B
  p52 subunit, RELB; Transcription factor RelB, BCL3; B-Cell CLL/Lymphoma 3, FBXL15;
  F-Box and Leucine-Rich Repeat Protein 15, GBF1; Golgi Brefeldin A Resistant Guanine
  Nucleotide Exchange Factor 1, NF-kB2; nuclear factor-kappa B2, RPARP-AS1; RPARP
  antisense RNA 1.'
papertitle: NF-kB2 Genetic Variations are Significantly Associated with Non-Small
  Cell Lung Cancer Risk and Overall Survival.
reftext: Foteinos-Ioannis D. Dimitrakopoulos, et al. Sci Rep. 2018;8:5259.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7564764
figid_alias: PMC5869671__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Danio rerio
redirect_from: /figures/PMC5869671__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5869671__41598_2018_23324_Fig1_HTML.html
  '@type': Dataset
  description: '(A) Schematic diagram of the alternative pathway of NF-kB (Reprinted
    from Lung Cancer, 89, 3, Dimitrakopoulos et al., 311–319, Variant of BCL3 gene
    is strongly associated with five-year survival of non-small-cell lung cancer patients,
    2015, with permission from Elsevier). (B) Genomic positions of studied SNPs in
    NF-kB2 gene. (C) The study design outline. Abbreviations: BAFFR; tumor necrosis
    factor receptor superfamily member 13 C, CD40; CD40 molecule, TNF receptor superfamily
    member 5, LTβR; Lymphotoxin Beta Receptor (TNFR Superfamily, Member 3), RANK;
    Receptor Activator Of Nuclear Factor-Kappa B, NIK; NF-Kappa-Beta-Inducing Kinase,
    IKKα; IκB Kinase α, p100; nuclear factor NF-kappa-B p100 subunit, p52; nuclear
    factor NF-kappa-B p52 subunit, RELB; Transcription factor RelB, BCL3; B-Cell CLL/Lymphoma
    3, FBXL15; F-Box and Leucine-Rich Repeat Protein 15, GBF1; Golgi Brefeldin A Resistant
    Guanine Nucleotide Exchange Factor 1, NF-kB2; nuclear factor-kappa B2, RPARP-AS1;
    RPARP antisense RNA 1.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TNFRSF13C
  - CD40
  - LTBR
  - TNFRSF11A
  - MAP3K14
  - MAP4K4
  - CUX1
  - NFKB2
  - OAS3
  - PMEL
  - SART3
  - TPX2
  - SND1
  - ASCC2
  - RELB
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - FKBP4
  - GTF2H4
  - PMPCB
  - PSIP1
  - H3P42
  - GBF1
  - PTGES2
  - FBXL15
  - C10orf95-AS1
  - cd40
  - tnfrsf1b
  - nfkb2
  - relb
  - gbf1
  - fbxl15
---
